The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review
- PMID: 37860198
- PMCID: PMC10583548
- DOI: 10.3389/fonc.2023.1228076
The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review
Abstract
The increasing incidence of cancer globally has highlighted the significance of early diagnosis and improvement of treatment strategies. In the 19th century, a connection was made between inflammation and cancer, with inflammation recognized as a malignancy hallmark. The neutrophil-to-lymphocyte ratio (NLR), calculated from a complete blood count, is a simple and accessible biomarker of inflammation status. NLR has also been proven to be a prognostic factor for various medical conditions, including mortality classification in cardiac patients, infectious diseases, postoperative complications, and inflammatory states. In this narrative review, we aim to assess the prognostic potential of NLR in cancer. We will review recent studies that have evaluated the association between NLR and various malignancies. The results of this review will help to further understand the role of NLR in cancer prognosis and inform future research directions. With the increasing incidence of cancer, it is important to identify reliable and accessible prognostic markers to improve patient outcomes. The study of NLR in cancer may provide valuable insights into the development and progression of cancer and inform clinical decision-making.
Keywords: NLR; cancer prognosis; malignancy; neutrophil to lymphocyte ratio; prognostic factors.
Copyright © 2023 Heshmat-Ghahdarijani, Sarmadi, Heidari, Falahati Marvasti, Neshat and Raeisi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Neutrophil-to-lymphocyte ratio, past, present and future perspectives.Bratisl Lek Listy. 2021;122(7):474-488. doi: 10.4149/BLL_2021_078. Bratisl Lek Listy. 2021. PMID: 34161115
-
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.Eur Urol Focus. 2019 Nov;5(6):1085-1090. doi: 10.1016/j.euf.2018.06.008. Epub 2018 Jun 22. Eur Urol Focus. 2019. PMID: 29937330 Free PMC article.
-
Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.BMC Cancer. 2013 Jul 22;13:350. doi: 10.1186/1471-2407-13-350. BMC Cancer. 2013. PMID: 23876227 Free PMC article.
-
The neutrophil-to-lymphocyte ratio: a narrative review.Ecancermedicalscience. 2016 Dec 12;10:702. doi: 10.3332/ecancer.2016.702. eCollection 2016. Ecancermedicalscience. 2016. PMID: 28105073 Free PMC article. Review.
-
The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer.Onco Targets Ther. 2020 Feb 14;13:1397-1412. doi: 10.2147/OTT.S227171. eCollection 2020. Onco Targets Ther. 2020. PMID: 32104003 Free PMC article. Review.
Cited by
-
A Review of the Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Nonhematologic Malignancies.Diagnostics (Basel). 2024 Sep 16;14(18):2057. doi: 10.3390/diagnostics14182057. Diagnostics (Basel). 2024. PMID: 39335736 Free PMC article. Review.
-
Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitors.Ther Adv Med Oncol. 2024 Dec 15;16:17588359241305091. doi: 10.1177/17588359241305091. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39687055 Free PMC article.
-
Prognostic value of neutrophil-to-lymphocyte ratios pre- and post-surgery in stage III CRC: a study of 2,742 patients.Int J Colorectal Dis. 2024 Dec 20;39(1):206. doi: 10.1007/s00384-024-04789-3. Int J Colorectal Dis. 2024. PMID: 39702682 Free PMC article.
-
Investigation of association between clinically significant prostate cancer, obesity and platelet to-lymphocyte ratio and neutrophil -to-lymphocyte ratio.BMC Urol. 2024 Oct 16;24(1):226. doi: 10.1186/s12894-024-01617-2. BMC Urol. 2024. PMID: 39407194 Free PMC article.
-
New Biomarkers for Patients With Fungal Keratitis From Blood Routine Examination: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.J Ophthalmol. 2025 Mar 11;2025:5594701. doi: 10.1155/joph/5594701. eCollection 2025. J Ophthalmol. 2025. PMID: 40114778 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources